The latest market analysis reveals that the global fabry disease market is poised for significant growth, with a projected valuation of US$ 4.10 billion by 2032. According to comprehensive research, the market, valued at US$ 1.9 billion in 2022, is anticipated to witness a robust Compound Annual Growth Rate (CAGR) of 8% over the forecast …